NCT07313397

Brief Summary

The goal of this proposed single-group pre-post pilot study is to assess the feasibility and acceptability of the codesigned Nurse-led and GP-supported self-management interventions (NGPS) to reduce cardiovascular risks in breast cancer survivors with cardiovascular diseases. The study will also assess the preliminary effects of the NGPS intervention on various outcomes, such as behavioural, physiological, psychological, and healthcare usage. These outcomes will be measured at three time points, which include the baseline measurement at recruitment (T1-week 1), right after the four weeks' intervention (T2-week 4), and eight weeks after completing the intervention (T3-week 12). The study will be conducted in the primary care centres, and the self-management interventions are behavioural change interventions such as physical activity, diet modifications, tobacco cessation, weight management, eliminating or reducing alcohol consumption, and mind-body exercises such as yoga. The main questions it aims to answer are:

  1. 1.What are the recruitment, retention, attrition, and completion rates of participants and potential adverse effects related to the NGPS interventions for the participants throughout the pilot study?
  2. 2.What are the adherence rates of the NGPS protocol, participants' response and completion rates of the study instruments during the data collection period of the pilot study?
  3. 3.Do this pilot study results indicate any significant differences in cardiovascular health outcomes (e.g., BMI and blood pressure), physical activity, dietary intake, QoL, self-efficacy, anxiety and depression between and across different time points (Baseline (T1), post-intervention (T2), follow-up (T3))?

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable breast-cancer

Timeline
9mo left

Started Mar 2026

Shorter than P25 for not_applicable breast-cancer

Geographic Reach
1 country

3 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Mar 2026Feb 2027

First Submitted

Initial submission to the registry

November 13, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 31, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Last Updated

January 8, 2026

Status Verified

January 1, 2026

Enrollment Period

9 months

First QC Date

November 13, 2025

Last Update Submit

January 6, 2026

Conditions

Keywords

Breast CancerCardiovascular diseaseSelf-management InterventionsBreast Cancer Suvivors

Outcome Measures

Primary Outcomes (9)

  • Baseline Information

    Collect socio-demographic characteristics of the breast cancer survivors such as age, height, race/ethinicity, religion, education level, marital status, employment status and annual household income as well as medical history

    Once at baseline

  • Feasibility of recruitment

    Number of weeks/months needed to reach target sample size

    From recruitment start (Day 1 of the recruitment) to recruitment close (the day that the target sample reached), up to 12 months

  • Recruitment rate

    The percentage of eligible (or approached) participants who actually agree to take part in the study.

    Recruitment rate will be assessed monthly over the recruitment period (up to 12 months).

  • Retention rate

    The percentage of participants who remain in the study

    Across the entire trial period, from enrolment to eight weeks post study follow-up

  • Dropout rate

    The percentage of participants dropped out after the study enrolment

    Across the entire trial period, from enrolment to eight weeks post study follow-up

  • Feasibility of the questionnaires

    The percentage of missing responses for each item and the entire scale in each questionnaires

    Across the entire trial period, from enrolment to eight weeks post study follow-up

  • Feasibility and acceptability of the study intervention- Adherence rate

    The percentage of participants who followed the prescribed interventions as intended

    From week one to week four, during the intervention period

  • Safety of the intervention- Adverse Events related to the Nurse-led and GP-supported self-management (NGPS) intervention

    Asking the participants to record any discomfort feelings or adverse events related to the NGPS intervention, keeping daily logbook and report via telephone or face-to-face

    From week one to week four, during the intervention period

  • Acceptability of the intervention

    Feedback on the NGPS program will be gained by using an investigator-created questionnaire. Participants are asked to specify the extent to which they agree with each statement about the intervention by selecting one response option that best indicates their views. The numeric value will range from 1 to 5, where 1 indicates strongly disagree, 2 indicates disagree, 3 indicates neither agree nor disagree, 4 indicates agree, and 5 indicates strongly agree. The minimum value is 1, and the maximum score is 5. Higher scores indicate greater acceptability of the intervention and a better outcome.

    At eight-week follow up

Secondary Outcomes (10)

  • Physiological outcomes- BMI

    At baseline (T1), immediately post intervention (T2), and eight-week follow-up (T3)

  • Physiological outcomes-blood pressure

    At baseline (T1), immediately post intervention (T2), and eight-week follow-up (T3)

  • Physiological outcomes-heart rate

    At baseline (T1), immediately post intervention (T2), and eight-week follow-up (T3)

  • Behavioural outcomes using 15-item food frequency questionnaire

    At baseline (T1), immediately post intervention (T2), and eight-week follow-up (T3)

  • Behavioural outcomes- Self-reported smoking status

    At baseline (T1), immediately post intervention (T2), and eight-week follow-up (T3)

  • +5 more secondary outcomes

Study Arms (1)

Self-management intervention group

EXPERIMENTAL

A combined face-to-face and telehealth self-management intervention will be conducted over four weeks, following assessment of the patients' cardiac condition, breast cancer, health literacy, and access to resources. The interventions will be carried out mainly by nurses, GPs, and allied health professionals, who will be included if needed. Patients and caregivers will be involved in the sessions. The self-management interventions will be behaviour change interventions, such as physical exercise, dietary modifications, smoking cessation and weight management.

Other: Self-management Interventions

Interventions

Self-management interventions will cover physical activity, smoking cessation, weight management, diet modifications, eliminate or reduce alcohol consumption and mind-body exercise such as taichi, yoga.

Self-management intervention group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale breast cancer survivors
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged 18 years or older
  • confirmed diagnosis of breast cancer at stage I, II, or IIIa
  • confirmed diagnosis of CVDs, including heart failure, coronary artery disease, stroke, or transient ischemic attack
  • able to read, write, and communicate in English
  • have completed active anticancer treatment including chemotherapy and radiotherapy, and are receiving regular healthcare in a primary care centre from GP/practice nurses and are willing to participate in the research study and provide informed consent.

You may not qualify if:

  • patients with unstable health conditions with mental health issues or critically ill patients unable to participate in physical activities (e.g., suffering from life-threatening diseases, extremely weak), cognitive impairment, currently involved in another research study, or scheduled anticancer treatment during the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Greens Medical Group, Dandenong South

Melbourne, Victoria, 3173, Australia

Location

Keys Medical Centre, Keysborough

Melbourne, Victoria, 3173, Australia

Location

TLC Medical Clinic, Noble Park

Melbourne, Victoria, 3173, Australia

Location

MeSH Terms

Conditions

Breast NeoplasmsCardiovascular Diseases

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Alison Wang, PhD

    University of Southern Queensland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anu Correya, Masters

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 13, 2025

First Posted

December 31, 2025

Study Start

March 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

February 1, 2027

Last Updated

January 8, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations